Last Price
0.408
Today's Change
-0.29 (41.54%)
Day's Change
0.375 - 0.643
Trading Volume
9,962,175
Market Cap
12 Million
Shares Outstanding
30 Million
Avg Volume
239,604
Avg Price (50 Days)
0.69
Avg Price (200 Days)
1.63
PE Ratio
-0.36
EPS
-1.14
Earnings Announcement
12-Nov-2024
Previous Close
0.70
Open
0.64
Day's Range
0.375 - 0.643
Year Range
0.375 - 9.372
Trading Volume
9,998,477
1 Day Change
-41.62%
5 Day Change
-43.38%
1 Month Change
-42.93%
3 Month Change
-41.90%
6 Month Change
-91.47%
Ytd Change
-65.47%
1 Year Change
-58.69%
3 Year Change
-97.08%
5 Year Change
-95.64%
10 Year Change
-95.64%
Max Change
-95.64%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.